Dana Inc/ US2358252052 /
05/06/2024 19:04:06 | Chg. +0.07 | Volume | Bid19:07:59 | Ask19:07:59 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
13.72USD | +0.51% | 13,603 Turnover: 185,474.36 |
13.71Bid Size: 112 | 13.74Ask Size: 100 | 1.99 bill.USD | 2.92% | 52.75 |
GlobeNewswire
04/06
Verisk’s National Equipment Register (NER) and KYCS Global Collaborate to Enhance Heavy Equipment Se...
GlobeNewswire
02/06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
28/05
LiquidStack to Showcase Immersion Cooling Technology at Cisco Live's Sustainability Zone
GlobeNewswire
23/05
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire
20/05
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponso...
GlobeNewswire
15/05
Pacific Software Inc. Secures Strategic License Agreement with the University of California for Inno...
GlobeNewswire
13/05
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Confere...
GlobeNewswire
10/05
Open Space Institute Holds 50th Anniversary Gala Honoring Founders John & Patricia Adams and Longtim...
GlobeNewswire
09/05
Konica Minolta’s Jason Dizzine and Dana Drury Named as ENX Magazine 2024 Difference Makers
GlobeNewswire
08/05
LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activatio...
GlobeNewswire
06/05
Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire
29/04
Wabash Recognized with Two Plant Safety Awards at Mexico and Kentucky Operations